Tenet receives $32 price target — 3 facts

Analysts gave Dallas-based Tenet Healthcare a $32 price target, according to Realist Investor.

Advertisement

Here are three facts:

1. Based on 11 stock opinions, Tenet’s rating score is currently 1.93.

2. For the fiscal year 2016, Tenet has estimated earnings per share of $1.59.

3. In other news, Tenet added two independent directors to its board of directors: John P. Byrnes and Peter M. Wilver.

More articles on surgery centers:
12 new ASCs in October 2016
3 recent ASC acquisitions — November 4, 2016
How physicians and hospitals can benefit from joint ventures

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.